SERPINB6 Promotes Epithelial‐Mesenchymal Transition via PI3K / AKT / mTOR Signalling Pathway in Glioma
Journal of Cellular and Molecular Medicine · 2025
DOI: 10.1111/jcmm.70711 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Ding Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, Zhejiang, People's Republ…. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, TOR Serine-Threonine Kinases, Proto-Oncogene Proteins c-akt, Glioma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Zhejiang medical and healthy technology project, Science and Technology Development Project of Hangzhou, Joint Funds of the Zhejiang Provincial Natural Science Foundation of China.
Abstract (Originalsprache)
Glioma is the most common and highly invasive type of brain cancer in the central nervous system, characterised by a low survival rate and poor prognosis. The role of SERPINB6 has been proven crucial in programmed necrosis and cancer progression. However, its role in glioma has not yet been clearly defined. This study utilised bioinformatics methods and in vitro and in vivo experiments to assess the expression, function and potential mechanisms of SERPINB6 in the development of glioma. Our study found that SERPINB6 plays a carcinogenic role in glioma, and its expression level is significantly negatively correlated with patient prognosis. The study also found that inhibiting SERPINB6 expression can hinder the epithelial‐mesenchymal transition (EMT) of glioma cells. Conversely, overexpression of SERPINB6 aggravated the occurrence of EMT. Particularly noteworthy is the mechanism of SERPINB6 in promoting EMT in glioma, which is achieved through the activation of the PI3K/AKT/mTOR signalling pathway. By activating the PI3K/AKT/mTOR pathway, SERPINB6 promotes EMT in glioma, demonstrating its great potential as a new target for glioma treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, Zhejiang, People's Republic of China.
ORCID-Profile: Quan Du
Förderung
- Zhejiang medical and healthy technology project
- Science and Technology Development Project of Hangzhou
- Joint Funds of the Zhejiang Provincial Natural Science Foundation of China
Zitieren
APA
Wang, D., Wang, H., Zheng, W., Wang, H., Yu, W., & Du, Q. (2025). SERPINB6 Promotes Epithelial‐Mesenchymal Transition via PI3K / AKT / mTOR Signalling Pathway in Glioma. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70711
Vancouver
Wang D, Wang H, Zheng W, Wang H, Yu W, Du Q. SERPINB6 Promotes Epithelial‐Mesenchymal Transition via PI3K / AKT / mTOR Signalling Pathway in Glioma. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70711
BibTeX
@article{Wang2025,
author = {Wang, Ding and Wang, Haiyang and Zheng, Wenhao and Wang, Heng and Yu, Wenhua and Du, Quan},
title = {SERPINB6 Promotes Epithelial‐Mesenchymal Transition via PI3K / AKT / mTOR Signalling Pathway in Glioma},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
doi = {10.1111/jcmm.70711}
}
EUVIMED